CraniUS is a biotech company and Johns Hopkins spinout based in Baltimore’s Woodberry neighborhood. As of 2023, it is developing a novel medical device whose medicine delivery mechanism bypasses the blood-brain barrier, primarily serves people with chronic brain diseases and aims to administer medication more effectively than other current treatments.